| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/15/2002 | WO2002062203A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/15/2002 | WO2002050101A8 Retinoblastoma-binding protein |
| 08/15/2002 | WO2002046404A9 Schizophrenia-related voltage-gated ion channel gene and protein |
| 08/15/2002 | WO2002038793A3 Hepatitis c virus constructs characterized by high efficiency replication |
| 08/15/2002 | WO2002032937A3 Neuromedin u delta |
| 08/15/2002 | WO2002024734A3 Influenza a virus haemagglutinin subtype h16 proteins and their encoding nuclei c acid |
| 08/15/2002 | WO2002020567A3 Mammalian cystatin-8 and its use to inhibit cancer procoagulant protein |
| 08/15/2002 | WO2002018589A3 Nucleotide sequence coding for the sigc gene of corynebacterium glutamicum |
| 08/15/2002 | WO2002018369A3 Peptidomimetic protease inhibitors |
| 08/15/2002 | WO2002016590A3 Methods and compositions for increasing protein yield from a cell culture |
| 08/15/2002 | WO2002014870A3 Use of antibodies against specific mhc-peptide complexes |
| 08/15/2002 | WO2002013763A3 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 08/15/2002 | WO2002008261A3 Bstp-trans protein and related reagents and methods of use thereof |
| 08/15/2002 | WO2002006303A3 Dna vaccines encoding hiv accessory proteins |
| 08/15/2002 | WO2002002621A3 Mammalian secreted proteins |
| 08/15/2002 | WO2002000884A3 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome |
| 08/15/2002 | WO2001098516A3 Siderophores-producing bifidobacteria thereby and uses thereof |
| 08/15/2002 | WO2001096875A9 Hcv antigen/antibody combination assay |
| 08/15/2002 | WO2001096582A3 Plant-signalling ligand like proteins |
| 08/15/2002 | WO2001094390A3 52906, 33408, and 12189, potassium channel family members and uses thereof |
| 08/15/2002 | WO2001092321A3 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 08/15/2002 | WO2001092303A3 Human ion channels |
| 08/15/2002 | WO2001087285A3 Inhibition of the interaction of psd93 and psd95 with the nnos and nmda receptors |
| 08/15/2002 | WO2001083819A3 Methods for designing exogenous regulatory molecules |
| 08/15/2002 | WO2001083526A3 Calcitonin-related molecules |
| 08/15/2002 | WO2001077177A3 Gpcr-proteins and nucleic acids encoding same |
| 08/15/2002 | WO2001072825A3 Apoptin-associating protein |
| 08/15/2002 | WO2001072824A3 Apoptin-associating protein |
| 08/15/2002 | WO2001066753A3 Human genes and gene expression products |
| 08/15/2002 | WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 08/15/2002 | WO2001060858A3 Process for the preparation of a mucosal form of the eosinophil cationic protein (ecp), mucosal ecp and uses thereof as allergic phlogosis marker |
| 08/15/2002 | WO2001057079A3 C1 inhibitor produced in the milk of transgenic mammals |
| 08/15/2002 | WO2001044273A3 Receptor-selective somatostatin analogs |
| 08/15/2002 | WO2001040309A9 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 08/15/2002 | WO2001036447A3 Hormone receptor functional entities and methods of their use |
| 08/15/2002 | WO2001034801A9 Recombinant gelatin in vaccines |
| 08/15/2002 | WO2001034625A9 Isolation and characterization of human nf-e4 |
| 08/15/2002 | WO2001033955A9 Animal models for cardiac disease |
| 08/15/2002 | WO2001032927A3 Tissue specific genes of diagnostic import |
| 08/15/2002 | WO2001032877A9 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 08/15/2002 | WO2001032222A9 Selective toxin expression in angiogenic endothelial cells |
| 08/15/2002 | WO2001019856A3 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 08/15/2002 | WO2001018248A3 Quorum sensing signaling in bacteria |
| 08/15/2002 | WO2001016182A3 POLYPEPTIDES THAT BIND HIV gp120 AND RELATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE |
| 08/15/2002 | WO1999064067A9 Vaccine |
| 08/15/2002 | US20020112259 Plant retroelements and methods related thereto |
| 08/15/2002 | US20020112258 Methods of using viral replicase polynucleotides and polypeptides |
| 08/15/2002 | US20020112256 Expression vector for use in generating animal model for use in evaluation and treatment of pain disorders |
| 08/15/2002 | US20020112252 See-through medaka |
| 08/15/2002 | US20020112251 Nuclelotide sequences for use in the treatment proliferative defects |
| 08/15/2002 | US20020112026 Apparatuses, methods, and computer programs for displaying information on signs |
| 08/15/2002 | US20020111478 Novel human ion channel protein and polynucleotides encoding the same |
| 08/15/2002 | US20020111477 Novel human transporter proteins and polynucleotides encoding the same |
| 08/15/2002 | US20020111476 Polypeptide for use in the treatment of autoimmune diseases; for use as microbiocides |
| 08/15/2002 | US20020111475 Flt3-L mutants and methods of use |
| 08/15/2002 | US20020111474 Chimeric chains for receptor-associated signal transduction pathways |
| 08/15/2002 | US20020111473 Novel g protein coupled receptor |
| 08/15/2002 | US20020111472 T1-r ligand iii |
| 08/15/2002 | US20020111471 Nucleotide sequences coding polypeptide for use in the treatment of central nervous system, psychological and apoptosis disorders |
| 08/15/2002 | US20020111470 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 08/15/2002 | US20020111468 Nucleotide sequences coding for the sigD gene |
| 08/15/2002 | US20020111467 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/15/2002 | US20020111464 Diagnostic kit for detecting microorganismal infections in animals |
| 08/15/2002 | US20020111463 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 08/15/2002 | US20020111462 Nuclelotide sequences coding peptide for use in the treatment of autoimmune diseases |
| 08/15/2002 | US20020111461 Peptidomimetic compound for us ein the treatment of diabetes |
| 08/15/2002 | US20020111460 Polypeptide for use in the treatment of blood coagulation, proteolysis, complement activation, fertilization, and hormone generation defects; for use as wound healing agents |
| 08/15/2002 | US20020111331 FGF-affinity chromatography |
| 08/15/2002 | US20020111325 VEGI, an inhibitor of angiogenesis and tumor growth |
| 08/15/2002 | US20020111324 Adeno-associated virus-mediated delivery of angiogenic factors |
| 08/15/2002 | US20020111312 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 08/15/2002 | US20020111309 Therapeutic applications of laminin and laminin-derived protein fragments |
| 08/15/2002 | US20020111308 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020111305 Antiviral peptides |
| 08/15/2002 | US20020111304 Methods and compositions for treating fibrotic diseases |
| 08/15/2002 | US20020111303 Protein found in breast, prostate gland cells cancer membrane |
| 08/15/2002 | US20020111302 Novel nucleic acids and polypeptides |
| 08/15/2002 | US20020111299 Family of peptides known as xenoxins |
| 08/15/2002 | US20020111146 Apparatuses, methods, and computer programs for displaying information on signs |
| 08/15/2002 | US20020110913 Human cell culture for use in the generation of erythropoietin |
| 08/15/2002 | US20020110909 Glycoprotein hormone superagonists |
| 08/15/2002 | US20020110896 Expression vector coding envelope protein for use in prevention and treatment of infections; for use in gene therapy |
| 08/15/2002 | US20020110893 Novel human bcl-x-like proteins and polynucleotides encoding the same |
| 08/15/2002 | US20020110890 Expression vector for use in the monitoring of cyclic adenosine monophosphate concentration |
| 08/15/2002 | US20020110887 Protein for use in the treatment of sepsis, liver and blood disorders |
| 08/15/2002 | US20020110886 Proteins for use in the treatment of cell proliferative disorders |
| 08/15/2002 | US20020110883 Novel motor proteins and methods for their use |
| 08/15/2002 | US20020110877 Nucleotide sequences which code for the metE gene |
| 08/15/2002 | US20020110872 Cytotoxic factors for modulating cell death |
| 08/15/2002 | US20020110871 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
| 08/15/2002 | US20020110870 Therapeutic applications for CCR5 chemokine receptors |
| 08/15/2002 | US20020110868 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 08/15/2002 | US20020110867 Cardiac and pancreatic protein and gene |
| 08/15/2002 | US20020110866 Nucleotide sequences coding viral capsid protein; for use in the diagnosis, treatment and/or vaccination |
| 08/15/2002 | US20020110865 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 08/15/2002 | US20020110864 Polypeptide and DNAs encoding it |
| 08/15/2002 | US20020110862 Novel Siglec-like gene |
| 08/15/2002 | US20020110861 Expression vectors for use as tools for controlling gene expression in genetic engineering |
| 08/15/2002 | US20020110860 Chimeric polypeptides for use as gene expression tool in genetic engineering |